- Correction
- Open Access
- Published:
Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs
BMC Veterinary Research volume 15, Article number: 347 (2019)
The Original Article was published on 29 August 2019
Correction to: BMC Vet Res (2019) 15:309
https://doi.org/10.1186/s12917-019-2052-0
The original article [1] contains two mistaken instances of the molecule ‘fipronil’ in the results. These should instead have stated ‘firocoxib’.
Reference
de Salazar Alcalá AG, Gioda L, Dehman A, Beugnet F. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs. BMC Vet Res. 2019;15:309. https://doi.org/10.1186/s12917-019-2052-0.
Author information
Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
de Salazar Alcalá, A.G., Gioda, L., Dehman, A. et al. Correction to: Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs. BMC Vet Res 15, 347 (2019). https://doi.org/10.1186/s12917-019-2116-1
Published:
DOI: https://doi.org/10.1186/s12917-019-2116-1